[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Telmisartan Market Report 2017

February 2017 | 118 pages | ID: U3731F9DF99EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Telmisartan

Revenue, means the sales value of Telmisartan

This report studies sales (consumption) of Telmisartan in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Pfizer
  • Teva
  • Boehringer Ingelheim
  • Novartis
  • Mylan
  • Reddy'S Laboratories (Uk) Limited
  • Hema Pharmaceuticals Pvt
  • Bayer
  • Gsk
  • Astellas Pharma Inc
  • Nippon Boehringer Ingelheim Co
  • Abbott
  • Takeda
  • Beijing Wansheng Pharmaceutical
  • China Resources Double Crane Pharmaceutical
  • Yichang Changjiang Pharmaceutical
  • Wanbang Biopharmaceuticals
  • Hainan Selection Pharmaceutical
  • Dawnrays Pharmaceutical Limited
  • Hidaa Lifescience
  • Ratiopharm
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Injection
  • Freeze-Dried Powder
Split by applications, this report focuses on sales, market share and growth rate of Telmisartan in each application, can be divided into
  • Hospital Use
  • Clinic
  • Others
United States Telmisartan Market Report 2017

1 TELMISARTAN OVERVIEW

1.1 Product Overview and Scope of Telmisartan
1.2 Classification of Telmisartan
  1.2.1 Injection
  1.2.2 Freeze-Dried Powder
1.3 Application of Telmisartan
  1.3.1 Hospital Use
  1.3.2 Clinic
  1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Telmisartan (2012-2022)
  1.4.1 United States Telmisartan Sales and Growth Rate (2012-2022)
  1.4.2 United States Telmisartan Revenue and Growth Rate (2012-2022)

2 UNITED STATES TELMISARTAN COMPETITION BY MANUFACTURERS

2.1 United States Telmisartan Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Telmisartan Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Telmisartan Average Price by Manufactures (2015 and 2016)
2.4 Telmisartan Market Competitive Situation and Trends
  2.4.1 Telmisartan Market Concentration Rate
  2.4.2 Telmisartan Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES TELMISARTAN SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Telmisartan Sales and Market Share by States (2012-2017)
3.2 United States Telmisartan Revenue and Market Share by States (2012-2017)
3.3 United States Telmisartan Price by States (2012-2017)

4 UNITED STATES TELMISARTAN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Telmisartan Sales and Market Share by Type (2012-2017)
4.2 United States Telmisartan Revenue and Market Share by Type (2012-2017)
4.3 United States Telmisartan Price by Type (2012-2017)
4.4 United States Telmisartan Sales Growth Rate by Type (2012-2017)

5 UNITED STATES TELMISARTAN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Telmisartan Sales and Market Share by Application (2012-2017)
5.2 United States Telmisartan Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES TELMISARTAN MANUFACTURERS PROFILES/ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Telmisartan Product Type, Application and Specification
    6.1.2.1 Injection
    6.1.2.2 Freeze-Dried Powder
  6.1.3 Pfizer Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Teva
  6.2.2 Telmisartan Product Type, Application and Specification
    6.2.2.1 Injection
    6.2.2.2 Freeze-Dried Powder
  6.2.3 Teva Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.2 Telmisartan Product Type, Application and Specification
    6.3.2.1 Injection
    6.3.2.2 Freeze-Dried Powder
  6.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.2 Telmisartan Product Type, Application and Specification
    6.4.2.1 Injection
    6.4.2.2 Freeze-Dried Powder
  6.4.3 Novartis Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mylan
  6.5.2 Telmisartan Product Type, Application and Specification
    6.5.2.1 Injection
    6.5.2.2 Freeze-Dried Powder
  6.5.3 Mylan Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Reddy'S Laboratories (Uk) Limited
  6.6.2 Telmisartan Product Type, Application and Specification
    6.6.2.1 Injection
    6.6.2.2 Freeze-Dried Powder
  6.6.3 Reddy'S Laboratories (Uk) Limited Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Hema Pharmaceuticals Pvt
  6.7.2 Telmisartan Product Type, Application and Specification
    6.7.2.1 Injection
    6.7.2.2 Freeze-Dried Powder
  6.7.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer
  6.8.2 Telmisartan Product Type, Application and Specification
    6.8.2.1 Injection
    6.8.2.2 Freeze-Dried Powder
  6.8.3 Bayer Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Gsk
  6.9.2 Telmisartan Product Type, Application and Specification
    6.9.2.1 Injection
    6.9.2.2 Freeze-Dried Powder
  6.9.3 Gsk Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Astellas Pharma Inc
  6.10.2 Telmisartan Product Type, Application and Specification
    6.10.2.1 Injection
    6.10.2.2 Freeze-Dried Powder
  6.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Nippon Boehringer Ingelheim Co
6.12 Abbott
6.13 Takeda
6.14 Beijing Wansheng Pharmaceutical
6.15 China Resources Double Crane Pharmaceutical
6.16 Yichang Changjiang Pharmaceutical
6.17 Wanbang Biopharmaceuticals
6.18 Hainan Selection Pharmaceutical
6.19 Dawnrays Pharmaceutical Limited
6.20 Hidaa Lifescience
6.21 Ratiopharm

7 TELMISARTAN MANUFACTURING COST ANALYSIS

7.1 Telmisartan Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Telmisartan

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Telmisartan Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Telmisartan Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES TELMISARTAN MARKET FORECAST (2017-2022)

11.1 United States Telmisartan Sales, Revenue Forecast (2017-2022)
11.2 United States Telmisartan Sales Forecast by Type (2017-2022)
11.3 United States Telmisartan Sales Forecast by Application (2017-2022)
11.4 Telmisartan Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Telmisartan
Table Classification of Telmisartan
Figure United States Sales Market Share of Telmisartan by Type in 2015
Figure Injection Picture
Figure Freeze-Dried Powder Picture
Table Application of Telmisartan
Figure United States Sales Market Share of Telmisartan by Application in 2015
Figure Hospital Use Examples
Figure Clinic Examples
Figure Others Examples
Figure United States Telmisartan Sales and Growth Rate (2012-2022)
Figure United States Telmisartan Revenue and Growth Rate (2012-2022)
Table United States Telmisartan Sales of Key Manufacturers (2015 and 2016)
Table United States Telmisartan Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Telmisartan Sales Share by Manufacturers
Figure 2016 Telmisartan Sales Share by Manufacturers
Table United States Telmisartan Revenue by Manufacturers (2015 and 2016)
Table United States Telmisartan Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Telmisartan Revenue Share by Manufacturers
Table 2016 United States Telmisartan Revenue Share by Manufacturers
Table United States Market Telmisartan Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Telmisartan Average Price of Key Manufacturers in 2015
Figure Telmisartan Market Share of Top 3 Manufacturers
Figure Telmisartan Market Share of Top 5 Manufacturers
Table United States Telmisartan Sales by States (2012-2017)
Table United States Telmisartan Sales Share by States (2012-2017)
Figure United States Telmisartan Sales Market Share by States in 2015
Table United States Telmisartan Revenue and Market Share by States (2012-2017)
Table United States Telmisartan Revenue Share by States (2012-2017)
Figure Revenue Market Share of Telmisartan by States (2012-2017)
Table United States Telmisartan Price by States (2012-2017)
Table United States Telmisartan Sales by Type (2012-2017)
Table United States Telmisartan Sales Share by Type (2012-2017)
Figure United States Telmisartan Sales Market Share by Type in 2015
Table United States Telmisartan Revenue and Market Share by Type (2012-2017)
Table United States Telmisartan Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Telmisartan by Type (2012-2017)
Table United States Telmisartan Price by Type (2012-2017)
Figure United States Telmisartan Sales Growth Rate by Type (2012-2017)
Table United States Telmisartan Sales by Application (2012-2017)
Table United States Telmisartan Sales Market Share by Application (2012-2017)
Figure United States Telmisartan Sales Market Share by Application in 2015
Table United States Telmisartan Sales Growth Rate by Application (2012-2017)
Figure United States Telmisartan Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Telmisartan Sales Market Share (2012-2017)
Table Teva Basic Information List
Table Teva Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Telmisartan Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Telmisartan Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Telmisartan Sales Market Share (2012-2017)
Table Mylan Basic Information List
Table Mylan Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Telmisartan Sales Market Share (2012-2017)
Table Reddy'S Laboratories (Uk) Limited Basic Information List
Table Reddy'S Laboratories (Uk) Limited Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Reddy'S Laboratories (Uk) Limited Telmisartan Sales Market Share (2012-2017)
Table Hema Pharmaceuticals Pvt Basic Information List
Table Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hema Pharmaceuticals Pvt Telmisartan Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Telmisartan Sales Market Share (2012-2017)
Table Gsk Basic Information List
Table Gsk Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Gsk Telmisartan Sales Market Share (2012-2017)
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc Telmisartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Pharma Inc Telmisartan Sales Market Share (2012-2017)
Table Nippon Boehringer Ingelheim Co Basic Information List
Table Abbott Basic Information List
Table Takeda Basic Information List
Table Beijing Wansheng Pharmaceutical Basic Information List
Table China Resources Double Crane Pharmaceutical Basic Information List
Table Yichang Changjiang Pharmaceutical Basic Information List
Table Wanbang Biopharmaceuticals Basic Information List
Table Hainan Selection Pharmaceutical Basic Information List
Table Dawnrays Pharmaceutical Limited Basic Information List
Table Hidaa Lifescience Basic Information List
Table Ratiopharm Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Telmisartan
Figure Manufacturing Process Analysis of Telmisartan
Figure Telmisartan Industrial Chain Analysis
Table Raw Materials Sources of Telmisartan Major Manufacturers in 2015
Table Major Buyers of Telmisartan
Table Distributors/Traders List
Figure United States Telmisartan Production and Growth Rate Forecast (2017-2022)
Figure United States Telmisartan Revenue and Growth Rate Forecast (2017-2022)
Table United States Telmisartan Production Forecast by Type (2017-2022)
Table United States Telmisartan Consumption Forecast by Application (2017-2022)
Table United States Telmisartan Sales Forecast by States (2017-2022)
Table United States Telmisartan Sales Share Forecast by States (2017-2022)


More Publications